SPOTLIGHT: Bear deal gives JPMorgan big healthcare stake


If JPMorgan manages to close its bargain-basement rate acquisition of Bear Stearns, JP Morgan will be picking up a big piece of healthcare business. The question is, what to do with it? Bear Stearns has a meaningful healthcare group in place within its investment banking unit, but it comes with some baggage. This includes a recent whistle-blower lawsuit filed by execs at an Illinois hospital who claimed that a Bear exec tried to force them to use both Bear and a particular construction company when looking for CON approval. Makes one wonder how well the rumored "cowboy" culture at Bear will mix with JPMorgan's folks. Article

Suggested Articles

Healthcare’s RCM processes are in dire need of a 21st-century update that delivers greater automation and real-time transparency.

Amazon's PillPack and Surescripts, owned by CVS Health and Express Scripts, are in a dispute over access to patient medication history data.

Presidential candidate Kamala Harris wants to get rid of the tax break drug companies get for direct-to-consumer advertising.